| (CNY) | Dec 2025 | Y/Y change |
|---|---|---|
| Revenue | 1.24B | — |
| Operating expense | — | — |
| Net income | 0.00 | — |
| Net profit margin | — | — |
| Earnings per share | — | — |
| EBITDA | — | — |
| Effective tax rate | — | — |
Over the past year, 002399.SZ returned -21.0% with dividends reinvested.
| Period | Total return |
|---|---|
| YTD | -10.4% |
| 1 year | -21.0% |
| 5 years | -30.9% |
| 10 years | -35.8% |
| All-time high | ¥50.47 (Nov 2010) |
Returns are total returns and include reinvested dividends. The all-time high is the highest monthly closing price on record.
See what ¥1,000 in 002399.SZ would be worth today ›Yes. Shenzhen Hepalink Pharmaceutical Group Co., Ltd. paid 1 dividend over the past 12 months. The most recent was ¥0.15 per share on Jun 18, 2026. The dividend yield is 1.41%.
Shenzhen Hepalink Pharmaceutical Group Co., Ltd. is part of the Healthcare sector.
Shenzhen Hepalink Pharmaceutical Group Co., Ltd. has a market cap of 15.26B CNY, based on the latest quote.
